- Professor, Ronald O. Perelman Department of Dermatology
- American Board of Dermatology - Dermatology, 1970
Education and Training
- Residency, NYU Medical Center, Dermatology, 1970
- Residency, Mount Sinai Medical Center, Medicine, 1965
- MD from Columbia University, 1963
Locations and Appointments
- UnitedHealthcare Top Tier
Research My Research
Trained in both pharmacology and dermatology, with the experience of 20 years of clinical drug trials in a specially designed facility, fully staffed with individuals familiar with regulatory requirements and with the support of a major The Ronald O. Perelman Department of Dermatology, Jerome Shupack, M.D. is an ideal collaborator for new dermatologic drug development.
The Clinical Studies Unit is the center for clinical drug trials at New York University's Ronald O. Perelman Department of Dermatology. Projects undertaken in this facility include studies of treatment for: onychomycosis, tinea pedis, sun damaged skin, acne, psoriasis, male pattern baldness, atopic dermatitis, rosacea, Kaposi's sarcoma, and foot and leg ulcers. Research into analytical tools to evaluate the skin has also been centered in the Clinical Studies Unit. It has its own designated clinical space within the Skin and Cancer Unit. A room for intensive dermatologic treatments, including intravenous medication, has recently been added. Two full time research nurses (RN) work in the unit and are certified chemotherapy nurses as well as experienced data managers. A full-time secretary is available to assist with research records.
The Unit is contiguous with the Skin and Cancer Unit at the NYU Ambulatory Care Center. Specialty clinics in the department include: leg ulcer, hair, nail, pigmented lesion, psoriasis, bullous disease, contact dermatitis, photomedicine, disorders of keratinization, pediatric and surgery. There are two full-time medical photographers with a studio adjacent to the Clinical Studies Unit. Experts in dermatopathology and immunofluorescence are readily accessible to the Clinical Studies Unit.
Current and upcoming studies include treatments for male pattern baldness, foot ulcers, psoriasis, atopic dermatitis, onychomycosis, genital herpes, Kaposi's sarcoma, and rosacea. The current studies involve oral and topical medicines. Studies involving intravenous medication and photodynamic therapy have recently began.
Research Interests Timeline
Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine
Glazer, Alex M; Sofen, Bryan D; Rigel, Darrell S; Shupack, Jerome L Glazer, Alex M; Sofen, Bryan D; Rigel, Darrell S; Shupack, Jerome L
Journal of drugs in dermatology : JDD. 2017 Mar 1. 16 (3): 280-282
Schaffer, Panta Rouhani; Hale, Christopher S; Meehan, Shane A; Shupack, Jerome L; Ramachandran, Sarika Schaffer, Panta Rouhani; Hale, Christopher S; Meehan, Shane A; Shupack, Jerome L; Ramachandran, Sarika
Dermatology online journal. 2014 Dec 16. 20 (12): ?-?
Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab
Becker, Joanna G; Mundi, Jyoti P; Newlove, Tracey; Mones, Joan; Shupack, Jerome Becker, Joanna G; Mundi, Jyoti P; Newlove, Tracey; Mones, Joan; Shupack, Jerome
Journal of the American Academy of Dermatology. 2012 Oct. 67 (4): e150-e151